Stock of Interest

Posted On: October 19, 2023

#NECLIFE (NSE) Stock Report | 18 Oct 2023

Nectar Lifesciences Ltd is an India-based pharmaceutical company. It is engaged in manufacturing specialized pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and finished dosage formulations. It operates in the business segment of Pharmaceuticals Products, The company’s product includes cefixime trihydrate, cefdinir, cefprozil, cefoxitin sodium, cefpirome sulphate, and others. Geographically, it derives a majority of its revenue from India.

#xCalData predicts that # NECLIFE will continue its bearish phase over the next five days and trend within the range of 21 to 25.

In comparison to the previous month, the price of the stock has experienced a decline of 7.03% indicating a bearish.

The Stock has doubled once since 26 Feb 2015 and took an average of 0.6 years to double.

The stock has shown seasonality trend in the past.

Reviewing the returns for the past 5 years for the same week, we see the stock has given negative returns in 5 years in the past.

Majority of the technical ratios trend towards Bearish side of the spectrum. Only some of the technical indicators namely KST indicate Bullish view.

Collectively, xCalData suggests the stock would be in Bearish zone for next 5 days.

#xCalData is an exceptional app available for Android devices that offers unbiased insights into stocks, allowing investors to make informed decisions. With its user-friendly interface and comprehensive features, xCalData provides a valuable resource for anyone interested in the stock market.  Download the app from google play.

For Actionable Intelligence, subscribe to xCalData app on Android devices: https://tinyurl.com/downloadxCalData